Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B C Jacobs

Showing results (41-50 of 76) with videos related to

Pageof 8
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2001
Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The NetherlandsM Koga, C W Ang, N Yuki, et al.
Neurology|January 12, 2005
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndromeK Geleijns, G M Th Schreuder, B C Jacobs, et al.
Neurology|September 1, 1996
Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study GroupL H Visser, F G van der Meché, J Meulstee, et al.
Neurology|April 6, 2000
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndromeC W Ang, B C Jacobs, A H Brandenburg, et al.
Neurology|October 22, 1998
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control studyB C Jacobs, P H Rothbarth, F G van der Meché, et al.
Brain : a Journal of Neurology|August 1, 1995
Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study GroupL H Visser, F G Van der Meché, P A Van Doorn, et al.
Journal of Neuroimmunology|March 14, 2000
Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbitsC W Ang, H P Endtz, B C Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2012
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndromeA P Heikema, B C Jacobs, D Horst-Kreft, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trialM P J Garssen, P I M Schmitz, I S J Merkies, et al.
Infection and Immunity|March 20, 2001
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbitsC W Ang, M A De Klerk, H P Endtz, et al.
Pageof 8

Showing results (41-50 of 76) with videos related to

Sort By:
Pageof 8
Journal of Neurology, Neurosurgery, and Psychiatry|April 20, 2001
Comparative study of preceding Campylobacter jejuni infection in Guillain-Barré syndrome in Japan and The NetherlandsM Koga, C W Ang, N Yuki, et al.
Neurology|January 12, 2005
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndromeK Geleijns, G M Th Schreuder, B C Jacobs, et al.
Neurology|September 1, 1996
Cytomegalovirus infection and Guillain-Barré syndrome: the clinical, electrophysiologic, and prognostic features. Dutch Guillain-Barré Study GroupL H Visser, F G van der Meché, J Meulstee, et al.
Neurology|April 6, 2000
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndromeC W Ang, B C Jacobs, A H Brandenburg, et al.
Neurology|October 22, 1998
The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control studyB C Jacobs, P H Rothbarth, F G van der Meché, et al.
Brain : a Journal of Neurology|August 1, 1995
Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study GroupL H Visser, F G Van der Meché, P A Van Doorn, et al.
Journal of Neuroimmunology|March 14, 2000
Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbitsC W Ang, H P Endtz, B C Jacobs, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|November 24, 2012
Siglec-7 specifically recognizes Campylobacter jejuni strains associated with oculomotor weakness in Guillain-Barré syndrome and Miller Fisher syndromeA P Heikema, B C Jacobs, D Horst-Kreft, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 20, 2005
Amantadine for treatment of fatigue in Guillain-Barre syndrome: a randomised, double blind, placebo controlled, crossover trialM P J Garssen, P I M Schmitz, I S J Merkies, et al.
Infection and Immunity|March 20, 2001
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbitsC W Ang, M A De Klerk, H P Endtz, et al.
Pageof 8